Healthcare Resource Use and Economic Burden of B-Cell Acute Lymphoblastic Leukemia for Patients in the United States

Darzalex (daratumumab) - J&J

Blincyto (blinatumomab) - Amgen

Rituxan (rituximab) - Roche

Besponsa (inotuzumab ozogamicin) - Pfizer

nelarabine - Generic mfg.

https://www.sciencedirect.com/science/article/abs/pii/S2152265026016472

Neil D Palmisiano MD,MS 1; Yazan K Barqawi PharmD,PhD,MS,MBA 2; Julia Ma MS 3; Debbie Adkins MS PhD 4; Jesica M Levingston Mac Leod PhD 5; Jenny Lam MS PhD 2

Sep 1, 2026